At the forefront of therapies for rare and orphan diseasesTM
HOME CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Investors
 



Home >> Investor Relations >> Press Releases

Press Releases

All Releases
View Summary Amicus Therapeutics to Present at the Leerink Partners 5th Annual Global Healthcare Conference
Feb 3, 2016
PDF 12.4 KB
View Summary Amicus Therapeutics Provides Full-Year 2016 Strategic Outlook and Financial Guidance
Jan 11, 2016
PDF 23.5 KB
View Summary Amicus Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference and 3rd Annual Dermatology Summit
Jan 4, 2016
PDF 14.1 KB
View Summary Amicus Therapeutics Commences Phase 1/2 Study of Novel ERT for Treatment of Pompe Disease
Dec 22, 2015
PDF 58.1 KB
View Summary Amicus Therapeutics to Present at Goldman Sachs US Emerging / SMID Cap Growth Conference
Nov 12, 2015
PDF 16.4 KB
View Summary Amicus Therapeutics Announces Third Quarter 2015 Financial Results and Corporate Updates
Nov 3, 2015
PDF 33.9 KB
View Summary Amicus Therapeutics to Announce Third Quarter 2015 Financial Results on November 3, 2015
Oct 27, 2015
PDF 15.3 KB
View Summary Amicus Therapeutics to Host FDA Update Conference Call Today
Oct 2, 2015
PDF 16.9 KB
View Summary Amicus Therapeutics Provides U.S. Regulatory Update for Migalastat Monotherapy
Oct 2, 2015
PDF 19.0 KB
View Summary Amicus Therapeutics Completes Acquisition of Scioderm, Inc.
Sep 30, 2015
PDF 23.7 KB
View Summary Amicus Therapeutics to Present at LEERINK Partners Rare Disease Roundtable
Sep 22, 2015
PDF 16.0 KB
View Summary Amicus Therapeutics Plans to Submit New Drug Application (NDA) for Migalastat for Fabry Disease Following Positive Pre-NDA Meeting With FDA
Sep 15, 2015
PDF 21.1 KB
View Summary Amicus Therapeutics to Acquire Rare Disease Company Scioderm, Inc.
Aug 31, 2015
PDF 30.1 KB
View Summary Amicus Therapeutics Announces Second Quarter 2015 Financial Results and Corporate Updates
Aug 5, 2015
PDF 32.6 KB
View Summary Amicus Therapeutics to Announce Second Quarter 2015 Financial Results on August 5, 2015
Jul 29, 2015
PDF 19.8 KB
View Summary Amicus Therapeutics Joins Russell 3000(R) and Russell 2000(R) Indexes
Jun 29, 2015
PDF 19.5 KB
View Summary Amicus Therapeutics Announces Galafold(TM) Marketing Authorization Application (MAA) Validated by European Medicines Agency (EMA)
Jun 25, 2015
PDF 23.6 KB
View Summary Amicus Therapeutics Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Over-Allotment Option
Jun 17, 2015
PDF 17.8 KB
View Summary Amicus Therapeutics Prices Underwritten Offering of Common Stock
Jun 11, 2015
PDF 21.6 KB
View Summary Amicus Therapeutics Announces Public Offering of Common Stock
Jun 10, 2015
PDF 22.8 KB
Showing 1-20 of 267 Page: 1 2 3 4 5 ... 14  Next 20

Copyright © 2016 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy